Completed
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
NCT00949650
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +11 more
- Locations
-
- Highlands Oncology Group Fayetteville, Arkansas, United States
- Clinical Trials and Research Associates Inc Montebello, California, United States
- Innovative Medical Research of South Florida Miami, Florida, United States
- Crescent City Research Consortiom Marrero, Louisiana, United States